Table 3.
Total n=51 | Survivors n=35 | Non-survivors n=16 | p* | |
---|---|---|---|---|
Time to active therapy, days, mean ± SD | 2.5 ± 2.2 | 2.6 ± 2.2 | 2.1 ± 2.1 | |
Tigecycline, n (%) | 47 (92) | 33 (94) | 14 (88) | |
-Duration, days, mean ± SD | 14.8±11.1 | 19.0±10.7 | 5.6±10.6 | .001 |
Colistin, n (%) | 19 (37) | 13 (39) | 6 (38) | |
-Duration, days, mean ± SD | 3.14±5.1 | 3.5±5.6 | 2.3±4.0 | |
Amikacin, n (%) | 24 (47) | 14 (40) | 10 (63) | |
-Duration, days, mean ± SD | 3.7±7.0 | 4.2±8.2 | 2.5±3.3 | |
Gentamicin, n (%) | 2 (4) | 2 (6) | 0 (0) | |
-Duration, days, mean ± SD | 0.35±2.3 | 0.35±2.3 | - |
Includes antibiotics given at any time after first positive blood culture.
univariate analysis.
SD: standard deviation.